Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Cash from Operations (2018 - 2025)

BioNexus Gene Lab's Cash from Operations history spans 8 years, with the latest figure at 961062.0 for Q4 2025.

  • Quarterly results put Cash from Operations at 961062.0 for Q4 2025, up 338.43% from a year ago — trailing twelve months through Dec 2025 was 1838382.0 (up 12.18% YoY), and the annual figure for FY2025 was 1838382.0, up 12.18%.
  • Cash from Operations for Q4 2025 was 961062.0 at BioNexus Gene Lab, up from 1237465.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 961062.0 in Q4 2025 to a low of 1603035.0 in Q3 2024.
  • The 5-year median for Cash from Operations is 77178.5 (2022), against an average of 259643.55.
  • The sharpest move saw Cash from Operations tumbled 2721.96% in 2024, then soared 338.43% in 2025.
  • Year by year, Cash from Operations stood at 483007.0 in 2021, then fell by 1.3% to 476739.0 in 2022, then tumbled by 264.14% to 782526.0 in 2023, then skyrocketed by 128.01% to 219203.0 in 2024, then soared by 338.43% to 961062.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 961062.0, 1237465.0, and 737907.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.